Obesity is a Disease
COVID-19 & Obesity
Obesity Call for Papers
“Long Covid” and Obesity
Over the past 2 years, Obesity has provided rapid online publication of manuscripts on obesity-related aspects of the COVID-19 epidemic. Emerging information indicates that after a SARS-CoV-2 diagnosis, 20% of individuals may develop persistent, unresolving symptoms that can last 4 weeks or longer, now termed post-acute sequelae of SARS-CoV-2 (PASC), and large-scale observational data suggests increasing BMI may be a risk factor.
As the official journal of The Obesity Society and the premier source of information for obesity research and discovery from basic to population science, Obesity seeks submission of scientific data on the following topics:
- Potential mechanistic drivers of “long COVID” in individuals with obesity, including immune impairment and subsequent reactivation of latent viruses such as cytomegalovirus, Epstein-Barr virus, or varicella zoster virus
- Effect of obesity and related psychological stressors on the resolution of symptoms and recovery rate across PASC phenotypes, including in socioeconomically disadvantaged and racial/ethnic minority populations
- Response to therapy, based on obesity status, in patients recovering from PASC
- Other possible contributors to PASC that may be of interest to readers of Obesity including development of autoantibodies, residual viral load of SARS-CoV-2 including in adipose tissue, damage to lungs and other organs, small fiber neuropathy, and microscopic blood clots
Accepted submissions will have rapid online publication ahead of print.
Please submit your manuscript at https://mc.manuscriptcentral.com/obesity, and be sure to read the latest COVID-19 research on our journal website.
News You Can Use
TOS Promotes National Childhood Obesity Awareness Month in September
Focus on Healthy Foods, Physical Activity
Medically-Supervised Pediatric Obesity Treatment Associated with Improved Psychosocial Health, But Access to Care is Limited
Medically-supervised pediatric obesity treatment is associated with improved psychosocial health and reduced symptoms of depression…
The Obesity Society Weighs In On the FDA Approval of Semaglutide 2.4 (Wegovy®)
…past presidents of The Obesity Society (TOS) are weighing in on its implications for the effective treatment of obesity…
Obesity and Cancer: Studies Highlight Different Aspects of the Connection
Multi-factorial metabolic and inflammatory abnormalities in obesity, independently or in combination, seems to be the critical biological link of obesity…